Compounds > thiophenes
Page last updated: 2024-08-18

thiophenes and Allergic Encephalomyelitis

thiophenes has been researched along with Allergic Encephalomyelitis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Atkins, AR; Bapat, SP; Burris, TP; Chang, C; Cho, H; Downes, M; Evans, RM; Kamenecka, TM; Leblanc, M; Liang, Y; Loo, CS; Solt, LA; Yu, RT; Zhao, X; Zheng, Y1
Balletta, S; Bruno, A; Bullitta, S; Buttari, F; Caioli, S; Centonze, D; De Vito, F; Dolcetti, E; Fresegna, D; Gentile, A; Guadalupi, L; Mandolesi, G; Musella, A; Nencini, M; Rizzo, FR; Sanna, K; Stampanoni Bassi, M; Vanni, V; Vitiello, L1
Brown, DA; Kuo, PC; Paraiso, HC; Scofield, BA; Wang, PY; Yen, JH; Yu, IC1
Gregor, P; Harris, N; Il'kova, G; Juhas, S; Karin, N; Kogan, FY; Koppel, J; Lahmy, O; Wildbaum, G; Zhuk, R; Zsila, F1
Brown, DA; Chang, FL; Kuo, PC; Scofield, BA; Wang, PY; Yen, JH; Yu, IC1
Galicia-Rosas, G; Gommerman, JL; Jian, A; Nuesslein-Hildesheim, B; Ostrowski, M; Pikor, N; Rojas, O; Schwartz, JA; Summers-Deluca, L1

Other Studies

6 other study(ies) available for thiophenes and Allergic Encephalomyelitis

ArticleYear
The nuclear receptor REV-ERBĪ± modulates Th17 cell-mediated autoimmune disease.
    Proceedings of the National Academy of Sciences of the United States of America, 2019, 09-10, Volume: 116, Issue:37

    Topics: Amino Acid Motifs; Animals; Cell Differentiation; Encephalomyelitis, Autoimmune, Experimental; Gene Expression Regulation; Genetic Loci; HEK293 Cells; Humans; Interleukin-17; Mice; Mice, Transgenic; Multiple Sclerosis; Nuclear Receptor Subfamily 1, Group D, Member 1; Nuclear Receptor Subfamily 1, Group F, Member 3; Pyrrolidines; Response Elements; RNA-Seq; Th17 Cells; Thiophenes

2019
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis.
    Cells, 2020, 05-22, Volume: 9, Issue:5

    Topics: Animals; Anti-Inflammatory Agents; beta-Alanine; Cell Line; Central Nervous System; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Glutamates; Indans; Interleukin-1beta; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Neostriatum; Oxadiazoles; RNA, Messenger; Sphingosine-1-Phosphate Receptors; Synapses; Synaptic Transmission; T-Lymphocytes; Thiophenes

2020
Dithiolethione ACDT suppresses neuroinflammation and ameliorates disease severity in experimental autoimmune encephalomyelitis.
    Brain, behavior, and immunity, 2018, Volume: 70

    Topics: Animals; Central Nervous System; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Macrophage Activation; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Myelin Sheath; Th1 Cells; Th17 Cells; Thiones; Thiophenes

2018
Mechanism of action and efficacy of RX-111, a thieno[2,3-c]pyridine derivative and small molecule inhibitor of protein interaction with glycosaminoglycans (SMIGs), in delayed-type hypersensitivity, TNBS-induced colitis and experimental autoimmune encephal
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2016, Volume: 65, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Cell Line, Tumor; Colitis; Encephalomyelitis, Autoimmune, Experimental; Heparitin Sulfate; Human Umbilical Vein Endothelial Cells; Humans; Hypersensitivity, Delayed; Leukocyte Rolling; Male; Mice, Inbred BALB C; Myelin Basic Protein; Oxazolone; Pyridines; Rats; Rats, Inbred Lew; T-Lymphocytes; Thiophenes; Treatment Outcome; Trinitrobenzenesulfonic Acid

2016
3H-1,2-dithiole-3-thione as a novel therapeutic agent for the treatment of experimental autoimmune encephalomyelitis.
    Brain, behavior, and immunity, 2016, Volume: 57

    Topics: Animals; Anti-Inflammatory Agents; Dendritic Cells; Encephalomyelitis, Autoimmune, Experimental; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Th1 Cells; Th17 Cells; Thiones; Thiophenes

2016
A sphingosine-1-phosphate receptor 1-directed agonist reduces central nervous system inflammation in a plasmacytoid dendritic cell-dependent manner.
    Journal of immunology (Baltimore, Md. : 1950), 2012, Oct-01, Volume: 189, Issue:7

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; B-Lymphocytes; beta-Alanine; Cell Aggregation; Dendritic Cells; Encephalomyelitis, Autoimmune, Experimental; Female; Inflammation; Mice; Receptors, Lysosphingolipid; Sphingosine-1-Phosphate Receptors; T-Lymphocytes; Thiophenes

2012